Slingshot members are tracking this event:
Actinium (ATNM) Initiates Phase 2 Trial Evaluating Actimab-A in Newly Diagnosed Acute Myeloid Leukemia Patients Over Age 60
Slingshot Insights Explained
Sep 27, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Trial Initiation, Phase 2, Actimab-a, Newly Diagnosed Acute Myeloid Leukemia, Age 60